Snowball logo
logo
SOLV

Solventum Corp.

$91.61+$0.36ย  (0.39%)
SOLV's financial performance over the past year re...
View AAPL example
Estimate
P/E
11
EPS
8.33
Beta
0.671
Growth
Revenue, YoY
2.22%
Net income, YoY
2.22%
FCF, YoY
144.07%
Forecast
P/E (FWD)
12.7
EPS (FWD)
7.224
About the company
Ticker
SOLV
ISIN
US83444M1018
Country
United States of America
Sector (GICS)
Healthcare
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Frequently asked questions

What sector does Solventum Corp. (SOLV) operate in?

Solventum Corp. belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Solventum Corp. (SOLV) current stock price?

As of the latest data, Solventum Corp. stock price is $91.61, with a previous close of $91.25. Solventum Corp. gained $0.36 in the last trading session, representing a 0.39% increase.

What is Solventum Corp. (SOLV) current market capitalization?

Solventum Corp. market cap is approximately 15.59 billion.

What is Solventum Corp. (SOLV) Earnings Per Share (EPS)?

The trailing EPS is $8.33, and the forward EPS is $7.22.

What is Solventum Corp. (SOLV) Price-to-Earnings (P/E) ratio?

Solventum Corp. current P/E ratio is 11, with a forward P/E of 12.68.

What is Solventum Corp. (SOLV) EBITDA?

Solventum Corp. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 172.00 million.

Does Solventum Corp. (SOLV) pay dividends?

No. Solventum Corp. does not pay a dividend.

How did Solventum Corp. (SOLV) perform in its most recent earnings report?

In the last report (June 30, 2026), Solventum Corp. posted an EPS surprise of 33.51% and a revenue surprise of 2.47%.

What is Solventum Corp. (SOLV) beta (volatility) score?

Solventum Corp. has a beta of 0.671, indicating lower volatility than the overall market.